Federation des caisses Desjardins du Quebec’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,305	Closed	-$87.5K	–	2350
2019 Q2	$87.5K	Sell	7,305 -22,592	-76%	-$243K	﹤0.01%	1342
2019 Q1	$361K	Hold	29,897	–	–	0.01%	809
2018 Q4	$376K	Sell	29,897 -14,788	-33%	-$204K	0.01%	775
2018 Q3	$664K	Hold	44,685	–	–	0.01%	695
2018 Q2	$753K	Hold	44,685	–	–	0.01%	686
2018 Q1	$1.02M	Buy	44,685 +19,491	+77%	+$434K	0.02%	611
2017 Q4	$650K	Buy	+25,194	New	+$507K	0.01%	699

Other funds holding CNCE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CNCE Position: Q3 2019 in Review

Federation des caisses Desjardins du Quebec sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2019, closing a stake of 7,305 shares — an estimated $87.5K sold.

Federation des caisses Desjardins du Quebec first reported a position in CNCE in Q4 2017 and held it in 7 quarters. The position peaked at $1.02M in Q1 2018. 80 funds tracked by Wall St. Rank hold CNCE as of Q3 2019.

Federation des caisses Desjardins du Quebec reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 7,305 Concert Pharmaceuticals, Inc. shares in Q3 2019, an estimated $87.5K.
Federation des caisses Desjardins du Quebec first reported a position in Concert Pharmaceuticals, Inc. in Q4 2017 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Concert Pharmaceuticals, Inc. position peaked at $1.02M in Q1 2018.
80 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2019, filed 30 Aug 2024.